Erratum: HLA-DRA Class II Molecule as a Marker for Immuno-Active Tumors and Its Role in Predicting Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
-
By
-
Jie Mei
-
Guanyu Jiang
-
Yundi Chen
-
Yongrui Xu
-
Yuan Wan
-
Ruo Chen
-
Feng Liu
-
Wenjun Mao
-
Mingfeng Zheng
-
Junying Xu
-
September 17, 2026